Utilize available clinical guidelines to accurately diagnose patients with severe asthma vs difficult-to-treat asthma
|
|
|
|
|
|
Utilize strategies to minimize the use of OCS in patients with severe asthma in order to reduce OCS-related adverse effects and improve quality of life
|
|
|
|
|
|
Differentiate between asthma phenotypes and endotypes and utilize biomarkers to guide asthma diagnosis and predict response to therapy
|
|
|
|
|
|
Utilize available clinical trial data and readily available biomarkers to select the most appropriate therapy for individual patients
|
|
|
|
|
|
Describe strategies to effectively monitor patients with severe asthma in order to assess response to therapy, adherence to treatment, and opportunities to optimize therapy on an ongoing basis
|
|
|
|
|
|